Member access

4-Traders Homepage  >  Shares  >  Amex  >  CEL-SCI Corporation       US1508374097

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases. The company's lead investigational therapy, Multikine, is being developed as a potential therapeutic agent... 
More about the company
Chart CEL-SCI CORPORATION
Duration : Period :
CEL-SCI Corporation Technical Analysis Chart | US1508374097 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 0,26 M
EBIT 2014 -24,5 M
Net income 2014 -22,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 0,26 M
EBIT 2015 -26,9 M
Net income 2015 -27,0 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 289x
Capi. / Sales 2015 289x
Capitalization 75,2 M
More Financials
Latest news on CEL-SCI CORPORATION
5d ago CEL SCI : Submission of Matters to a Vote of Security Holders (form 8-K)
5d ago CEL-SCI Has Been Cleared to Begin Patient Enrollment
6d ago CEL SCI : NEW STORY CEL-SCI Receives Regulatory Clearance to Expand Phase III He..
6d ago CEL SCI : Receives Regulatory Clearance to Expand Phase III Head and Neck Cancer..
7d ago CEL SCI : NEW STORY CEL-SCI Expands Its Phase III Head and Neck Cancer Trial int..
07/18 CEL SCI : Secures Regulatory OK to Bolster Its Phase III Head and Neck Cancer Tr..
07/17 CEL SCI : Expands Its Phase III Head and Neck Cancer Trial into Sri Lanka
07/16 CEL SCI : Receives $225,000 NIH Research Grant to Develop Rheumatoid Arthritis T..
07/16 CEL SCI : SVP Delivers Scientific Presentation on Rheumatoid Arthritis
07/15 CEL SCI : NEW STORY CEL-SCI Receives $225,000 NIH Research Grant to Develop Rheu..
07/15 CEL SCI : Receives $225,000 NIH Research Grant to Develop Rheumatoid Arthritis T..
07/11 CEL SCI : NEW STORY CEL-SCI Presents Rheumatoid Arthritis Data at the 12th Vacci..
More news
Comments 
Advertisement
Income Statement Evolution
CEL-SCI Corporation : Income Statement Evolution
More Financials
EPS Revisions
CEL-SCI Corporation : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF